Bleeding risk of short-term intensive statin therapy after coronary artery bypass grafting / 临床外科杂志
Journal of Clinical Surgery
; (12): 750-752, 2016.
Article
em Zh
| WPRIM
| ID: wpr-503111
Biblioteca responsável:
WPRO
ABSTRACT
Objective To observe the bleeding risk of short-term intensive statin therapy after coronary artery bypass grafting. Methods A total of 240 patients treated with coronary artery bypass grafting were randomly divided into group A(experimental group)and group B(control group). All pa-tients were normalized to conventional treatment and they were given low molecular weight heparin for an-ticoagulant therapy during the perioperative period. Patients in group A were given 40 mg of atorvastatin before surgery,and 40 mg of atorvastatin every night for one month after the surgery. Patients in group B were given 10 mg of atorvastatin every night during the treatment. One month after the operation,platelet aggregation rate and bleeding events of patients were compared. Results There were significant differ-ences in maximum platelet aggregation rate[(14. 5 ± 3. 7)% vs(38. 1 ± 7. 4)% ,P < 0. 05],inhibition rate of platelet aggregation[(79. 5 ± 4. 3)% vs(50. 8 ± 10. 2)% ,P < 0. 05],and incidence of postopera-tive bleeding[27. 5% vs 12. 5% ,P < 0. 05]between group A and B,respectively. Conclusion Short-term intensive statin therapy can increase the bleeding risk after coronary artery bypass grafting.
Texto completo:
1
Índice:
WPRIM
Tipo de estudo:
Etiology_studies
Idioma:
Zh
Revista:
Journal of Clinical Surgery
Ano de publicação:
2016
Tipo de documento:
Article